197 related articles for article (PubMed ID: 32980342)
1. Effect of Acid Suppressants on the Risk of COVID-19: A Propensity Score-Matched Study Using UK Biobank.
Fan X; Liu Z; Miyata T; Dasarathy S; Rotroff DM; Wu X; Poulsen KL; Nagy LE
Gastroenterology; 2021 Jan; 160(1):455-458.e5. PubMed ID: 32980342
[No Abstract] [Full Text] [Related]
2. Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
Wu CL; Lei WY; Wang JS; Lin CE; Chen CL; Wen SH
PLoS One; 2020; 15(11):e0242975. PubMed ID: 33253311
[TBL] [Abstract][Full Text] [Related]
3. Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.
Park J; You SC; Cho J; Park CH; Shin WG; Park RW; In Seo S
BMC Pharmacol Toxicol; 2022 Jan; 23(1):9. PubMed ID: 35039078
[TBL] [Abstract][Full Text] [Related]
4. A comment on 'the impact of statins, ace inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort'.
Choi NK; Chang Y; Park BJ
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1121-2. PubMed ID: 19852000
[No Abstract] [Full Text] [Related]
5. Gastric acid suppressants--too much of a good thing?
Logan IC; Sumukadas D; Witham MD
Age Ageing; 2010 Jul; 39(4):410-1. PubMed ID: 20507846
[No Abstract] [Full Text] [Related]
6. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
7. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
Landi SN; Sandler RS; Pate V; Lund JL
Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
[TBL] [Abstract][Full Text] [Related]
8. What is the optimum prophylaxis against gastrointestinal haemorrhage for patients undergoing adult cardiac surgery: histamine receptor antagonists, or proton-pump inhibitors?
Patel AJ; Som R
Interact Cardiovasc Thorac Surg; 2013 Mar; 16(3):356-60. PubMed ID: 23208652
[TBL] [Abstract][Full Text] [Related]
9. The impact of statins, ACE inhibitors and gastric acid suppressants on pneumonia mortality in a UK general practice population cohort.
Myles PR; Hubbard RB; Gibson JE; Pogson Z; Smith CJ; McKeever TM
Pharmacoepidemiol Drug Saf; 2009 Aug; 18(8):697-703. PubMed ID: 19455553
[TBL] [Abstract][Full Text] [Related]
10. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
[TBL] [Abstract][Full Text] [Related]
11. ANTISECRETORY TREATMENT FOR PEDIATRIC GASTROESOPHAGEAL REFLUX DISEASE - A SYSTEMATIC REVIEW.
Mattos ÂZ; Marchese GM; Fonseca BB; Kupski C; Machado MB
Arq Gastroenterol; 2017 Dec; 54(4):271-280. PubMed ID: 28954042
[TBL] [Abstract][Full Text] [Related]
12. Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19.
Elmunzer BJ; Wolf BJ; Scheiman JM; Tierney WM; Taylor JR;
Gastroenterology; 2021 Mar; 160(4):1417-1422.e14. PubMed ID: 33189702
[No Abstract] [Full Text] [Related]
13. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
Myles PR; Hubbard RB; McKeever TM; Pogson Z; Smith CJ; Gibson JE
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):269-75. PubMed ID: 19235776
[TBL] [Abstract][Full Text] [Related]
14. Acid-suppression medications and bacterial gastroenteritis: a population-based cohort study.
Wei L; Ratnayake L; Phillips G; McGuigan CC; Morant SV; Flynn RW; Mackenzie IS; MacDonald TM
Br J Clin Pharmacol; 2017 Jun; 83(6):1298-1308. PubMed ID: 28054368
[TBL] [Abstract][Full Text] [Related]
15. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
[TBL] [Abstract][Full Text] [Related]
16. Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists and Risk of Pneumonia in Patients with Acute Stroke.
Momosaki R; Yasunaga H; Matsui H; Fushimi K; Abo M
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1035-1040. PubMed ID: 26853142
[TBL] [Abstract][Full Text] [Related]
17. Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
Kim B; Jung JH; Han K; Kang S; Lee E; Chung H; Kim SG; Cho SJ
J Korean Med Sci; 2023 Apr; 38(13):e99. PubMed ID: 37012686
[TBL] [Abstract][Full Text] [Related]
18. Potential Biases in Studies of Acid-Suppressing Drugs and COVID-19 Infection.
Etminan M; Nazemipour M; Candidate MS; Mansournia MA
Gastroenterology; 2021 Apr; 160(5):1443-1446. PubMed ID: 33340538
[No Abstract] [Full Text] [Related]
19. Stress ulcer prophylaxis: friend or foe?
Macdonald JJ; Roberts JC; Washington S
Br J Hosp Med (Lond); 2012 Apr; 73(4):238. PubMed ID: 22585209
[No Abstract] [Full Text] [Related]
20. [Acid inhibition leads to vitamin b12 deficiency].
Zwicker J
Med Monatsschr Pharm; 2014 May; 37(5):190-1. PubMed ID: 24908938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
